EIF2AK3 and neoplasm: Pharmacodynamic analyses of the orthotopic CDA model showed reduced pERK levels and increased apoptosis in the tumours 4 h after treatment, followed by recovery of pathway activity at 24 h (Fig. 2g and Extended Data Fig. 2u).